Skip to content

46 Xx Disorder Of Sex Development C2936403

Published: July 22, 2026Updated: August 20, 2026

A variation in typical female sex development involving chromosomal, gonadal, or anatomical differences. Treatment and support are personalized based on individual medical needs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Salt-wasting crisis

Life-threatening condition with severe dehydration, low blood pressure, vomiting, and shock due to cortisol and aldosterone deficiency.

Seek emergency care immediately if baby shows lethargy, vomiting, poor feeding, or weight loss.

Ambiguous genitalia at birth

(genitourinary)

External genitalia that does not appear typically male or female, including partial fusion of labia and clitoromegaly.

Frequency: 90-95% of patients

Clitoromegaly

(genitourinary)

Enlargement of the clitoris exceeding normal female anatomy, often appearing as a small phallus.

Frequency: 80-90% of patients

Labial fusion

(genitourinary)

Partial or complete fusion of the labia minora, creating the appearance of a scrotal sac.

Frequency: 60-70% of patients

Excessive body hair growth

(dermatologic)

Excessive hair growth in a male pattern distribution, including face, chest, and back.

Frequency: 60-80% of patients

Deepened voice

(respiratory)

Progressive deepening of the voice due to androgen effects on vocal cords.

Frequency: 50-70% of patients

Primary amenorrhea

(reproductive)

Absence of menstrual periods by age 15 or after 3 years of no menses following breast development.

Frequency: 70-80% of untreated patients

Accelerated growth velocity

(endocrine)

Faster than expected growth in childhood leading to early closure of growth plates and short adult stature.

Frequency: 60-80% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Individualized Hormone Therapy

Tailored hormone replacement based on specific diagnosis, patient goals, and genetic makeup. May include estrogen, progesterone, or androgen therapy depending on individual needs.

medication
3

Multidisciplinary Psychosocial Support

Integrated psychological support including individual therapy, family involvement, and peer support connections. Addresses identity development, disclosure decisions, and coping strategies.

psychological

Additional treatment options

Genital Reconstruction Surgery

When desired by the patient, surgical intervention to align physical characteristics with gender identity. Requires thorough informed consent and psychological preparation.

surgical

Comprehensive Long-term Monitoring

Regular assessment of hormonal status, bone health, metabolic function, and psychological wellbeing through a coordinated DSD specialty team.

monitoring

Multidisciplinary DSD Team Care

Coordinated care involving endocrinology, urology, gynecology, psychology, genetics, and social work to address all aspects of DSD comprehensively.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 46 Xx Disorder Of Sex Development C2936403?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488-e500.

guideline2006View source →
2

Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006;2(3):148-162.

consensus2006View source →
3

American Academy of Pediatrics. Technical report: disorders of sex development. Pediatrics. 2008;121(4):e1161-e1172.

position_statement2008View source →
4

Mendoza N, Motos MA. Androgen insensitivity syndrome: a review. Endocrinol Nutr. 2013;60(8):457-466.

review2013View source →
5

Ostrer H. Disorders of sex development (DSD): of sex and gender. Curr Opin Endocrinol Diabetes Obes. 2012;19(3):198-204.

review2012View source →
6

Wisniewski AB, Batista RL, Costa EMF, et al. Management of 46,XX pure gonadal dysgenesis (swyer syndrome): a committee opinion. Fertil Steril. 2022;117(6):1189-1194.

guideline2022View source →
7

Grinspon RP, Ropelato MG, Bedecarrás P, et al. Gonadal dysgenesis and DSD: clinical spectrum and genetic basis. Ann Endocrinol (Paris). 2021;82(3-4):163-175.

review2021View source →
8

Kousta E, Papathanasiou A, Mastorakos G. Disorders of sex development: classification, genetics, and management. Endocr Dev. 2014;27:62-71.

meta_analysis2014View source →
9

Camats N, Flück CE, Audí L. disorders of sex development: genetic and clinical aspects. Front Endocrinol (Lausanne). 2020;11:604329.

clinical_trial2020View source →

Medication Comparisons

Compare medications used to treat 46 Xx Disorder Of Sex Development C2936403. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy